 SALT LAKE CITY, Feb. 8, 2022 PRNewswire -- Recursion NASDAQ: RXRX, the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its participation in the following upcoming investor conferences: SVB Leerink 11th Annual Global Healthcare Conference Monday, February 14 through Friday, February 18, 2022 Webcasts may be found in the investor section of the Recursion website at . About Recursion Recursion is the clinical-stage biotechnology company industrializing drug discovery by decoding biology. 